Terms: = Breast cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
276 results:
1. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in breast cancer.
Khoury T; Mendicino L; Payne Ondracek R; Yao S; Davis W; Omilian AR; Kwan ML; Roh JM; D'Addario L; Valice E; Fernandez D; Ergas IJ; Chua AV; Ambrosone CB; Kushi LH
JAMA Netw Open; 2024 Mar; 7(3):e243345. PubMed ID: 38517439
[TBL] [Abstract] [Full Text] [Related]
2. A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) - Study protocol.
Northgraves M; Cohen J; Harvey J; Huang C; Palmieri C; Pinder S; Roy P; Reynia S; Soares M; Cain H
PLoS One; 2024; 19(3):e0300339. PubMed ID: 38489298
[TBL] [Abstract] [Full Text] [Related]
3. Income Segregation, Conditional Cash Transfers, and breast cancer Mortality Among Women in Brazil.
Guimarães JMN; Pescarini JM; Sousa Filho JF; Ferreira A; Almeida MDCC; Gabrielli L; Dos-Santos-Silva I; Santos G; Barreto ML; Aquino EML
JAMA Netw Open; 2024 Jan; 7(1):e2353100. PubMed ID: 38270952
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Smith KL; Zhao F; Mayer IA; Tevaarwerk AJ; Garcia SF; Arteaga CL; Symmans WF; Park BH; Burnette BL; Makower DF; Block M; Morley KA; Jani CR; Mescher C; Dewani SJ; Brown-Glaberman U; Flaum LE; Mayer EL; Sikov WM; Rodler ET; DeMichele AM; Sparano JA; Wolff AC; Miller KD; Wagner LI
Cancer; 2024 May; 130(10):1747-1757. PubMed ID: 38236702
[TBL] [Abstract] [Full Text] [Related]
5. Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy.
Yang Z; Wang N; Han R; Tang Y; Chen H; Xie Y; Wang R; Tang L
Eur J Radiol; 2024 Feb; 171():111294. PubMed ID: 38218065
[TBL] [Abstract] [Full Text] [Related]
6. Performance Metrics of Screening Digital breast Tomosynthesis Based on Years Since a Prior breast cancer Diagnosis.
Do D; Mercaldo S; Bahl M
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330419. PubMed ID: 38117100
[No Abstract] [Full Text] [Related]
7. Surgery for liver metastases from primary breast cancer: A reconstructed individual patient data meta-analysis.
Masuda Y; Yeo MHX; Syn NL; Goh BKP; Koh YX
Eur J Surg Oncol; 2024 Jan; 50(1):107277. PubMed ID: 37995605
[TBL] [Abstract] [Full Text] [Related]
8. Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway.
Li X; Chen G; Wang F; Guo X; Zhang R; Liu P; Dong L; Yu W; Wang H; Wang H; Yu J
Clin Transl Med; 2023 Nov; 13(11):e1483. PubMed ID: 37965796
[TBL] [Abstract] [Full Text] [Related]
9. New insights into the cytotoxic effects of Thymus vulgaris essential oil on the human triple-negative breast cancer cell line MDA-MB-231.
Benedetti S; Nasoni MG; Luchetti F; Palma F
Toxicol In Vitro; 2023 Dec; 93():105705. PubMed ID: 37775061
[TBL] [Abstract] [Full Text] [Related]
10. Determinants of Patient Delay among Women with Carcinoma breast.
J SS; Rohini AM; Thajudheen RB; Elavally S
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3109-3115. PubMed ID: 37774062
[TBL] [Abstract] [Full Text] [Related]
11. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive breast cancer Cells via HDAC4.
Zhang M; Wang M; Jiang Z; Fu Z; Ma J; Gao S
Breast J; 2023; 2023():2875972. PubMed ID: 37711168
[TBL] [Abstract] [Full Text] [Related]
12. A quality improvement project to optimize access to psychosocial care for cancer survivors who experience fear of recurrence.
Pereira L; Nguyen P; Benea A; Townsley C
J Psychosoc Oncol; 2023; 41(6):721-731. PubMed ID: 37702764
[TBL] [Abstract] [Full Text] [Related]
13. Major complications after intraoperative radiotherapy with low-energy x-rays in early breast cancer.
Berger L; Grimm A; Sütterlin M; Spaich S; Sperk E; Tuschy B; Berlit S
Strahlenther Onkol; 2024 Apr; 200(4):276-286. PubMed ID: 37591980
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical characteristics of patients referred to cardio-oncology clinic].
Liang L; An T; Zhao XM; Huang LY; Tian PC; Guan JY; Zou CH; Zhang J; Zhang YH
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2183-2186. PubMed ID: 37482731
[TBL] [Abstract] [Full Text] [Related]
15. Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating ciap2/NFκB signaling.
Wang R; Wang Y; Liu X; Liu M; Sun L; Pan X; Hu H; Jiang B; Zou Y; Liu Q; Gong Y; Wang M; Sun G
Cell Death Dis; 2023 Jun; 14(6):388. PubMed ID: 37391410
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure treatment Continuation.
Takada S; Maeda H; Umehara K; Kuwahara S; Yamamoto M; Tomioka N; Takahashi M; Watanabe K; Hashishita H
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1955-1962. PubMed ID: 37378924
[TBL] [Abstract] [Full Text] [Related]
17. IncRNA XIST Stimulates Papillary Thyroid cancer Development through the miR-330-3p/PDE5A Axis.
Cai T; He Y; Peng B
Crit Rev Eukaryot Gene Expr; 2023; 33(3):13-26. PubMed ID: 37017666
[TBL] [Abstract] [Full Text] [Related]
18. Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
Nelson BE; Saleem S; Damodaran S; Somaiah N; Piha-Paul S; Moore JA; Yilmaz B; Ogbonna D; Karp DD; Dumbrava E; Tsimberidou AM; Hong DS; Rodon Ahnert J; Milton DR; Zheng X; Booser DJ; Ibrahim NK; Conley AP; Bhosale P; Rojas Hernandez CM; Tripathy D; Naing A; Meric-Bernstam F
Cancer; 2023 Jul; 129(14):2201-2213. PubMed ID: 37016732
[TBL] [Abstract] [Full Text] [Related]
19. Plasma hPG
Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
[TBL] [Abstract] [Full Text] [Related]
20. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
Senkus E; Delaloge S; Domchek SM; Conte P; Im SA; Xu B; Armstrong A; Masuda N; Fielding A; Robson M; Tung N
Int J Cancer; 2023 Aug; 153(4):803-814. PubMed ID: 36971103
[TBL] [Abstract] [Full Text] [Related]
[Next]
